Skip to Content

Ceftibuten Pregnancy and Breastfeeding Warnings

Ceftibuten is also known as: Cedax

Ceftibuten Pregnancy Warnings

Ceftibuten has been assigned to pregnancy category B by the FDA. Animal studies have failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy. Ceftibuten should be only given during pregnancy when need has been clearly established.

See references

Ceftibuten Breastfeeding Warnings

Ceftibuten is excreted into human milk in small amounts. Adverse effects in the nursing infant are unlikely. Although not specifically listing ceftibuten, the American Academy of Pediatrics classifies other cephalosporins as compatible with breast-feeding. The manufacturer recommends that caution be used when administering ceftibuten to nursing women.

See references

References for pregnancy information

  1. Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 5th ed." Baltimore, MD: Williams & Wilkins (1998):
  2. "Product Information. Cedax (ceftibuten)." Schering-Plough, Liberty Corner, NJ.

References for breastfeeding information

  1. "Product Information. Cedax (ceftibuten)." Schering-Plough, Liberty Corner, NJ.
  2. Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 5th ed." Baltimore, MD: Williams & Wilkins (1998):
  3. Owens RC, Nightingale CH, Nicolau DP "Ceftibuten: an overview." Pharmacotherapy 17 (1997): 707-20

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide